有关绝经期的激素替代治疗(HRT)影响罹患乳腺癌风险的争论已持续十余年;在瑞典进行的随机试验“乳腺癌被确诊后的激素替代疗法——是否安全(HABITS)的研究”提前终止将使争论逐步升级。HABITS的研究者们报道说,接受激素疗法与不用这种疗法相比不仅可增加乳腺癌的发病风险(26比7,相对危险性RR=3.5,95％CI为1.5～ The controversy over the impact of hormone replacement therapy (HRT) on breast cancer risk during menopause has persisted for more than a decade; the randomized trial “Hormone Replacement Therapy - HABITS Study in Breast Cancer” conducted in Sweden ahead of schedule Termination will escalate the controversy. HABITS researchers report that hormonal therapy not only increases the risk of developing breast cancer (26 versus 7, relative risk RR = 3.5, 95% CI,